213 related articles for article (PubMed ID: 25480827)
1. Chemotherapy dose adjustment for obese patients undergoing hematopoietic stem cell transplantation: a survey on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Shem-Tov N; Labopin M; Moukhtari L; Ciceri F; Esteve J; Giebel S; Gorin NC; Schmid C; Shimoni A; Nagler A; Mohty M
Oncologist; 2015 Jan; 20(1):50-5. PubMed ID: 25480827
[TBL] [Abstract][Full Text] [Related]
2. Impact of Dose-Adjusted Melphalan in Obese Patients Undergoing Autologous Stem Cell Transplantation.
Shultes KC; Arp C; Stockerl-Goldstein K; Trinkaus K; DeFrates S
Biol Blood Marrow Transplant; 2018 Apr; 24(4):687-693. PubMed ID: 29225163
[TBL] [Abstract][Full Text] [Related]
3. Intravenous busulfan in adults prior to haematopoietic stem cell transplantation: a population pharmacokinetic study.
Nguyen L; Leger F; Lennon S; Puozzo C
Cancer Chemother Pharmacol; 2006 Jan; 57(2):191-8. PubMed ID: 16133536
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Dose Adjustment Strategies for Obesity in High-dose Cyclophosphamide Among Adult Hematopoietic Cell Transplantation Recipients: Pharmacokinetic Analysis.
Takahashi T; Jaber MM; Al-Kofahi M; Weisdorf D; Brunstein C; Bachanova V; Brundage RC; Jacobson PA; Kirstein MN
Transplant Cell Ther; 2022 Dec; 28(12):845.e1-845.e8. PubMed ID: 36167308
[TBL] [Abstract][Full Text] [Related]
5. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT).
Aoudjhane M; Labopin M; Gorin NC; Shimoni A; Ruutu T; Kolb HJ; Frassoni F; Boiron JM; Yin JL; Finke J; Shouten H; Blaise D; Falda M; Fauser AA; Esteve J; Polge E; Slavin S; Niederwieser D; Nagler A; Rocha V;
Leukemia; 2005 Dec; 19(12):2304-12. PubMed ID: 16193083
[TBL] [Abstract][Full Text] [Related]
6. Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation.
Singhal S; Gordon LI; Tallman MS; Winter JN; Evens AM; Frankfurt O; Williams SF; Grinblatt D; Kaminer L; Meagher R; Mehta J
Bone Marrow Transplant; 2006 Mar; 37(6):553-7. PubMed ID: 16444282
[TBL] [Abstract][Full Text] [Related]
7. Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: a survey of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Giebel S; Miszczyk L; Slosarek K; Moukhtari L; Ciceri F; Esteve J; Gorin NC; Labopin M; Nagler A; Schmid C; Mohty M
Cancer; 2014 Sep; 120(17):2760-5. PubMed ID: 24804873
[TBL] [Abstract][Full Text] [Related]
8. Ideal Body Weight Is Useful For Predicting Neutrophil Engraftment and Platelet Recovery for Overweight and Obese Recipients in Single-Unit Cord Blood Transplantation.
Okada Y; Nakasone H; Konuma T; Uchida N; Tanaka M; Sugio Y; Aotsuka N; Nishijima A; Katsuoka Y; Ara T; Ota S; Onizuka M; Sawa M; Kimura T; Fukuda T; Atsuta Y; Kanda J; Kimura F
Transplant Cell Ther; 2022 Aug; 28(8):504.e1-504.e7. PubMed ID: 35577325
[TBL] [Abstract][Full Text] [Related]
9. Comparison of autologous peripheral blood stem cell dosing by ideal vs actual body weight.
Waples JM; Moreb JS; Sugrue M; Belanger G; Kubilis P; Lynch JW; Gian V; Weeks F; Wingard J
Bone Marrow Transplant; 1999 May; 23(9):867-73. PubMed ID: 10338040
[TBL] [Abstract][Full Text] [Related]
10. Ideal or actual body weight to calculate CD34+ cell doses for allogeneic hematopoietic stem cell transplantation?
Cilley J; Rihn C; Monreal J; Gordon LI; Singhal S; Tallman M; Williams S; Winter J; Mehta J
Bone Marrow Transplant; 2004 Jan; 33(2):161-4. PubMed ID: 14647242
[TBL] [Abstract][Full Text] [Related]
11. Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation.
Miano M; Labopin M; Hartmann O; Angelucci E; Cornish J; Gluckman E; Locatelli F; Fischer A; Egeler RM; Or R; Peters C; Ortega J; Veys P; Bordigoni P; Iori AP; Niethammer D; Rocha V; Dini G;
Bone Marrow Transplant; 2007 Jan; 39(2):89-99. PubMed ID: 17213848
[TBL] [Abstract][Full Text] [Related]
12. How to calculate the quantity of CD34+ cells infused? A single center cohort study based on actual, ideal or adjusted ideal body weight.
Topcuoglu P; Akcaglayan Soydan E; Ekiz F; Ayyildiz E; Dalva K; Ozcan M; Arslan O; Arat M; Ilhan O
Transfus Apher Sci; 2007 Jun; 36(3):275-80. PubMed ID: 17569588
[TBL] [Abstract][Full Text] [Related]
13. The use of adjusted ideal body weight for overweight patients undergoing HPC mobilisation for autologous transplantation.
Hicks C; Trickett A; Kwan YL; Ramanathan S
Ann Hematol; 2012 Nov; 91(11):1795-801. PubMed ID: 22836946
[TBL] [Abstract][Full Text] [Related]
14. Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey.
Gratwohl A; Baldomero H; Passweg J; Urbano-Ispizua A;
Bone Marrow Transplant; 2002 Dec; 30(12):813-31. PubMed ID: 12476273
[TBL] [Abstract][Full Text] [Related]
15. Obesity is associated with higher overall survival in patients undergoing an outpatient reduced-intensity conditioning hematopoietic stem cell transplant.
Jaime-Pérez JC; Colunga-Pedraza PR; Gutiérrez-Gurrola B; Brito-Ramírez AS; Gutiérrez-Aguirre H; Cantú-Rodríguez OG; Herrera-Garza JL; Gómez-Almaguer D
Blood Cells Mol Dis; 2013 Jun; 51(1):61-5. PubMed ID: 23422842
[TBL] [Abstract][Full Text] [Related]
16. Ideal body weight correlates better with engraftment after PBSC autograft than actual body weight, but is under-estimated in myeloma patients possibly due to disease-related height loss.
Maclean PS; Parker AN; McQuaker IG; Clark AD; Farrell E; Douglas KW
Bone Marrow Transplant; 2007 Oct; 40(7):665-9. PubMed ID: 17646841
[TBL] [Abstract][Full Text] [Related]
17. [Vaccination].
Graubner UB; Liese J; Belohradsky BH
Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.
Fassas A; Passweg JR; Anagnostopoulos A; Kazis A; Kozak T; Havrdova E; Carreras E; Graus F; Kashyap A; Openshaw H; Schipperus M; Deconinck E; Mancardi G; Marmont A; Hansz J; Rabusin M; Zuazu Nagore FJ; Besalduch J; Dentamaro T; Fouillard L; Hertenstein B; La Nasa G; Musso M; Papineschi F; Rowe JM; Saccardi R; Steck A; Kappos L; Gratwohl A; Tyndall A; Samijn J;
J Neurol; 2002 Aug; 249(8):1088-97. PubMed ID: 12195460
[TBL] [Abstract][Full Text] [Related]
19. A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Al-Ali HK; Brand R; van Biezen A; Finke J; Boogaerts M; Fauser AA; Egeler M; Cahn JY; Arnold R; Biersack H; Niederwieser D; de Witte T
Leukemia; 2007 Sep; 21(9):1945-51. PubMed ID: 17611571
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey.
Rasheed W; Ghavamzadeh A; Hamladji R; Ben Othman T; Alseraihy A; Abdel-Rahman F; Elhaddad A; Alabdulaaly A; Dennison D; Ibrahim A; Bazarbachi A; Bekadja MA; Mohamed SY; Adil SN; Ahmed P; Benchekroun S; Ramzi M; Jarrar M; Alimoghaddam K; Hussain F; Hamidieh A; Aljurf M
Hematol Oncol Stem Cell Ther; 2013 Mar; 6(1):14-9. PubMed ID: 23664600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
